Prevention of venous thromboembolism

Clinics in Geriatric Medicine

Volumn 17, Issue 1, 2001, Pages 71-92

  Heit, John A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DALTEPARIN; ENOXAPARIN; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; TINZAPARIN; WARFARIN;

AGED; BLEEDING; CEREBROVASCULAR ACCIDENT; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; GENERAL SURGERY; GERIATRIC CARE; GYNECOLOGIC SURGERY; HEART INFARCTION; HIP FRACTURE; HUMAN; LEG COMPRESSION; LUNG EMBOLISM; MULTIPLE TRAUMA; NEUROSURGERY; REVIEW; RISK FACTOR; SPINAL CORD HEMORRHAGE; SPINAL CORD INJURY; THROMBOCYTOPENIA; THROMBOEMBOLISM; THROMBOSIS; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; UROLOGIC SURGERY; VASCULAR SURGERY; VEIN THROMBOSIS;

EID: 0035118210     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0690(05)70107-5     Document Type: Article

References (56)

1. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery
2. Physician practices in the prevention of venous thromboembolism
3. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism
4. Collaborative overview of randomized trials of antiplatelet therapy-III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients
5. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
6. Underuse of venous thromboembolism prophylaxis for general surgery patients: Physician practices in the community hospital setting
7. Late deep venous thrombosis and delayed weightbearing after total hip arthroplasty
8. Antithrombotic agents in coronary disease
9. Prevention of venous thromboembolism
10. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty
11. Prevention of thromboembolism in spinal cord injury
12. Prolonged thromboprophylaxis following hip replacement surgery-results of a double-blind, prospective, randomized, placebocontrolled study with dalteparin (Fragmin)
13. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis
14. Inherited thrombophilia: Pathogenesis, clinical syndromes, and management
15. Calf-thigh sequential pneumatic compression compared with plantar venous pneumatic compression to prevent deep-vein thrombosis after non-lower extremity trauma
16. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment
17. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement
18. Economic analysis of low-dose heparin vs the low-molecular-weight heparin enoxaparin for prevention of venous thromboembolism after colorectal surgery
19. Two-step warfarin: Prevention of postoperative venous thrombosis without excessive bleeding
20. Comparison of two warfarin regimens in the prevention of venous thrombosis after total knee replacement
21. Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement
22. Prevention of deep-vein thrombosis after total hip arthroplasty: Comparison of warfarin and dalteparin
23. A prospective study of venous thromboembolism after major trauma
24. Sixth American College of Chest Physicians Consensus Conference on Antithrombotic Therapy: Prevention of venous thromboembolism
25. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma
26. Low molecular weight heparin: A critical analysis of clinical trials
27. Effect of delayed admission to the hospital on the preoperative prevalence of deep-vein thrombosis associated with fractures about the hip
28. Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after hip or knee replacement: A randomized, double-blind placebo-controled trial
29. Predictors of survival after deep vein thrombosis and pulmonary embolism
30. Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study
31. Low molecular weight heparin: Biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management
32. Preoperative vs. postoperative initiation of low molecular weight heparin prophylaxis against venous thomboembolism in patients undergoing elective hip replacement
33. Low molecular weight heparin using dalteparin extended out of hospital versus warfarin/out-of-hospital placebo in hip arthroplasty patients: A double-blind, randomized comparison
34. Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial
35. Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients
36. Starting prophylaxis for venous thromboembolism postoperatively
37. Efficacy and safety of prolonged thromboprophylaxis with low molecular weight heparin (dalteparin) after total hip arthroplasty: The Danish Prolonged Prophylaxis (DaPP) Study
38. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin. A multi-institutional cohort study in patients who underwent hip or knee arthroplasty
39. APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee: A prospective study
40. Prevention of venous thromboembolism after general surgery: Cost-effectiveness analysis of alternative approaches to prophylaxis
41. Death after proximal femoral fracture: An autopsy study
42. Low-molecular-weight heparin using dalteparin in close proximity to surgery versus warfarin in hip arthroplasty patients: A double-blind, randomized comparison
43. Prevention of deep vein thrombosis after hip replacement: Comparison between two low-molecular-weight heparins, tinzaparin and enoxaparin
44. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: Double-blind randomized comparison of enoxaparin and placebo
45. Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery
46. A comparison of general anesthesia and regional anesthesia as a risk factor for deep vein thrombosis following hip surgery: A critical review
47. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin
48. Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: The Post-Arthroplasty Screening Study
49. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients
50. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study
51. Anticoagulants and spinal-epidural anesthesia
52. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
53. Death and thromboembolic disease after total hip replacement
54. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty
55. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California
56. Spinal and epidural hematoma and low-molecular-weight heparin